Veradermics reports Q2 2026 results, completes enrollment in female pattern hair loss trialAug 11Quarterly updateVeradermics, Inc.
Veradermics files S-1 to register 16.8 million resale shares from PIPE investors and insidersAug 7FinancingVeradermics, Inc.
Veradermics reports positive Phase 2 data for oral VDPHL01 in female hair lossJul 15Clinical readoutVDPHL01Veradermics, Inc.
Sign inSign in